Guardant Health, Inc. (GH) Stock Analysis

Free AI-powered analysis and research for Guardant Health, Inc. stock

Sector: Healthcare

Analyze Guardant Health, Inc. (GH) Stock

Guardant Health, Inc. (GH) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into GH stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Guardant Health, Inc. stock.

Analyze GH Now →

📰 Latest Update

Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS®

Thu, June 11, 2026 at 12:05 PM UTC 3 min read

Guardant Health has received FDA approval for its Guardant360 CDx as a companion diagnostic for Boehringer Ingelheim’s HERNEXEOS®. This approval is significant for investors as it enhances Guardant's product portfolio and strengthens its position in the precision oncology market, potentially driving future revenue growth through increased adoption of its diagnostic solutions.

Read full article →